These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 15733729

  • 1. Regulatory role of peroxisome proliferator-activated receptor delta (PPAR delta) in muscle metabolism. A new target for metabolic syndrome treatment?
    Grimaldi PA.
    Biochimie; 2005 Jan; 87(1):5-8. PubMed ID: 15733729
    [Abstract] [Full Text] [Related]

  • 2. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome.
    Luquet S, Lopez-Soriano J, Holst D, Gaudel C, Jehl-Pietri C, Fredenrich A, Grimaldi PA.
    Biochimie; 2004 Nov; 86(11):833-7. PubMed ID: 15589693
    [Abstract] [Full Text] [Related]

  • 3. Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise.
    Kannisto K, Chibalin A, Glinghammar B, Zierath JR, Hamsten A, Ehrenborg E.
    Int J Mol Med; 2006 Jan; 17(1):45-52. PubMed ID: 16328010
    [Abstract] [Full Text] [Related]

  • 4. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors.
    Yumuk VD.
    Ann N Y Acad Sci; 2006 Nov; 1083():306-18. PubMed ID: 17148746
    [Abstract] [Full Text] [Related]

  • 5. Lipids, lipoproteins, and peroxisome proliferator activated receptor-delta.
    Sprecher DL.
    Am J Cardiol; 2007 Dec 03; 100(11 A):n20-4. PubMed ID: 18047848
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
    Wagner KD, Wagner N.
    Pharmacol Ther; 2010 Mar 03; 125(3):423-35. PubMed ID: 20026355
    [Abstract] [Full Text] [Related]

  • 7. Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor delta.
    Ehrenborg E, Krook A.
    Pharmacol Rev; 2009 Sep 03; 61(3):373-93. PubMed ID: 19805479
    [Abstract] [Full Text] [Related]

  • 8. Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta.
    Yan ZC, Liu DY, Zhang LL, Shen CY, Ma QL, Cao TB, Wang LJ, Nie H, Zidek W, Tepel M, Zhu ZM.
    Biochem Biophys Res Commun; 2007 Mar 09; 354(2):427-33. PubMed ID: 17223076
    [Abstract] [Full Text] [Related]

  • 9. Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes.
    Luquet S, Gaudel C, Holst D, Lopez-Soriano J, Jehl-Pietri C, Fredenrich A, Grimaldi PA.
    Biochim Biophys Acta; 2005 May 30; 1740(2):313-7. PubMed ID: 15949697
    [Abstract] [Full Text] [Related]

  • 10. Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonists.
    Fuster G, Busquets S, Ametller E, Olivan M, Almendro V, de Oliveira CC, Figueras M, López-Soriano FJ, Argilés JM.
    Cancer Res; 2007 Jul 01; 67(13):6512-9. PubMed ID: 17616713
    [Abstract] [Full Text] [Related]

  • 11. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
    Kawada T, Goto T, Hirai S, Kang MS, Uemura T, Yu R, Takahashi N.
    Asia Pac J Clin Nutr; 2008 Jul 01; 17 Suppl 1():126-30. PubMed ID: 18296319
    [Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator-activated receptors and the metabolic syndrome.
    Bragt MC, Popeijus HE.
    Physiol Behav; 2008 May 23; 94(2):187-97. PubMed ID: 18191967
    [Abstract] [Full Text] [Related]

  • 13. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V, Chinetti G, Fruchart JC, Staels B.
    J Soc Biol; 2002 May 23; 196(1):47-52. PubMed ID: 12134632
    [Abstract] [Full Text] [Related]

  • 14. Evolution of peroxisome proliferator-activated receptor agonists.
    Chang F, Jaber LA, Berlie HD, O'Connell MB.
    Ann Pharmacother; 2007 Jun 23; 41(6):973-83. PubMed ID: 17519293
    [Abstract] [Full Text] [Related]

  • 15. Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome.
    Guan Y.
    J Am Soc Nephrol; 2004 Nov 23; 15(11):2801-15. PubMed ID: 15504933
    [Abstract] [Full Text] [Related]

  • 16. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM, Schiffrin EL.
    Vascul Pharmacol; 2006 Jul 23; 45(1):19-28. PubMed ID: 16782410
    [Abstract] [Full Text] [Related]

  • 17. [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
    Alemán G, Torres N, Tovar AR.
    Rev Invest Clin; 2004 Jul 23; 56(3):351-67. PubMed ID: 15612519
    [Abstract] [Full Text] [Related]

  • 18. Roles of peroxisome proliferator-activated receptor delta in skeletal muscle function and adaptation.
    Fredenrich A, Grimaldi PA.
    Curr Opin Clin Nutr Metab Care; 2004 Jul 23; 7(4):377-81. PubMed ID: 15192438
    [Abstract] [Full Text] [Related]

  • 19. PPAR agonists: multimodal drugs for the treatment of type-2 diabetes.
    Gross B, Staels B.
    Best Pract Res Clin Endocrinol Metab; 2007 Dec 23; 21(4):687-710. PubMed ID: 18054742
    [Abstract] [Full Text] [Related]

  • 20. Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice.
    Chen W, Wang LL, Liu HY, Long L, Li S.
    Basic Clin Pharmacol Toxicol; 2008 Sep 23; 103(3):240-6. PubMed ID: 18684227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.